Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2566 USD | -3.90% | -9.10% | -89.13% |
05-09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.13% | 17.21M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Transcript : GlycoMimetics, Inc., Q1 2024 Earnings Call, May 06, 2024